| Carcinoma of Unknown Primary investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 325show all (up to 200) |
|---|
| → investigated in trials for | Pembrolizumabmonoclonal antibody 347 trials (162 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 347 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 270 trials (98 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 270 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 221 trials (90 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 221 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 218 trials (89 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 218 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 195 trials (85 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 195 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 189 trials (14 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 184 trials (69 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 184 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 177 trials (48 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 177 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 160 trials (41 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 160 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenvatinibsmall molecule 152 trials (67 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 152 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cetuximabmonoclonal antibody 114 trials (28 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 114 trials (33 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 108 trials (54 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 108 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 107 trials (39 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 107 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 102 trials (60 active) · roll-up of the cancer and its descendants | — | — | Carcinoma of Unknown Primary | 102 | Observed | clinicaltrials | graph → |